McCracken JT, Anagnostou E, Arango C, Dawson G, Farchione T, Mantua V, McPartland J, Murphy D, Pandina G, Veenstra-VanderWeele J (2021) Drug development for autism spectrum disorder (ASD): progress, challenges, and future directions
By mimicking the body's natural incretin hormones, it stimulates insulin secretion in response to meals and suppresses glucagon release, helping maintain stable blood glucose levels
( A ) Data revealing GLP-1stimulated insulin secretion supported the approval of the first GLP-1RA for the treatment of T2D in 2005
Brandt, L
The peptide cost calculator can help with detailed cost projections
Timeline: develops within 12 to 48 hours, may persist for 3 to 10 days